Urologic pharmacology in the office setting

Area of Science:

• Pharmacology
• Urology

Background:

• Common office therapeutics include anti-infective and micturition disorder treatments.
• Anti-infective therapy often considers pathogen susceptibility before administration.
• Micturition disorder therapy targets complex, conflicting mechanisms.

Purpose of the Study:

• To analyze the pharmacokinetic and pharmacodynamic principles in common office-based therapeutics.
• To identify reasons for therapeutic failures in anti-infective and micturition disorder treatments.

Main Methods:

• Review of pharmacodynamic principles in anti-infective drug action (in-vitro susceptibility).
• Analysis of pharmacokinetic factors influencing therapeutic success in anti-infective therapy.
• Examination of therapeutic approaches for micturition disorders in relation to pharmacokinetic tenets.

Main Results:

• Therapeutic failures in anti-infective therapy are frequently linked to unaddressed patient pharmacokinetics.
• Drug therapy for micturition disorders is rarely guided by pharmacokinetic principles.
• Existing treatments for micturition disorders are based on diverse, often opposing, mechanisms.

Conclusions:

• Optimizing anti-infective therapy requires a deeper understanding of individual patient pharmacokinetics.
• Current pharmacotherapy for micturition disorders may benefit from incorporating pharmacokinetic considerations.
• Further research into pharmacokinetic-guided treatments for micturition disorders is warranted.